Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.90
Delayed Data
As of 3:59pm ET
 +0.46 / +31.94%
Today’s Change
1.02
Today|||52-Week Range
2.60
+24.18%
Year-to-Date

Today’s Trading

Previous close1.44
Today’s open1.50
Day’s range1.45 - 2.01
Volume15,482,405
Average volume (3 months)797,957
Market cap$158.1M
Dividend yield--
Data as of 3:59pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book11.16

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...+0.55+8.15%
SBBPStrongbridge Biophar...0.000.00%
CPRXCatalyst Pharmaceuti...+0.03+1.53%
SMMTSummit Therapeutics ...-0.53-3.99%
Data as of 3:59pm ET, 03/30/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts


Search for Jobs